BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29974132)

  • 1. Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.
    Krug D; Baumann R; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
    Strahlenther Onkol; 2018 Sep; 194(9):797-805. PubMed ID: 29974132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
    Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
    Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
    Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
    Monrigal E; Dauplat J; Gimbergues P; Le Bouedec G; Peyronie M; Achard JL; Chollet P; Mouret-Reynier MA; Nabholtz JM; Pomel C
    Eur J Surg Oncol; 2011 Oct; 37(10):864-70. PubMed ID: 21843920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
    Huang L; Chen S; Yang WT; Shao Z
    Oncotarget; 2017 Jun; 8(24):39703-39710. PubMed ID: 28055977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy: A Review of the Evidence.
    Chapman CH; Jagsi R
    Oncology (Williston Park); 2015 Sep; 29(9):657-66. PubMed ID: 26384802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
    Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
    Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.
    Arsenault D; Hurley J; Takita C; Reis IM; Zhao W; Rodgers S; Wright JL
    Am J Clin Oncol; 2015 Aug; 38(4):348-52. PubMed ID: 23799288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current role of sentinel node biopsy in the treatment of breast cancer.
    Grube BJ; Giuliano AE
    Adv Surg; 2004; 38():121-66. PubMed ID: 15515617
    [No Abstract]   [Full Text] [Related]  

  • 12. Identifying accessible prognostic factors for breast cancer relapse: a case-study on 405 histologically confirmed node-negative patients.
    Zemni I; Ghalleb M; Jbir I; Slimane M; Ben Hassouna J; Ben Dhieb T; Bouzaiene H; Rahal K
    World J Surg Oncol; 2017 Nov; 15(1):206. PubMed ID: 29169398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
    Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
    Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast-conserving therapy in breast cancer].
    Marcollet A; Doridot V; Nos C
    Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657).
    Cureton EL; Yau C; Alvarado MD; Krontiras H; Ollila DW; Ewing CA; Monnier S; Esserman LJ
    Ann Surg Oncol; 2014 Sep; 21(9):2889-96. PubMed ID: 24788555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review.
    Krug D; Baumann R; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R
    Strahlenther Onkol; 2018 Jul; 194(7):607-618. PubMed ID: 29383405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in breast cancer.
    Charfare H; Limongelli S; Purushotham AD
    Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of sentinel node biopsy expands.
    Peres J
    J Natl Cancer Inst; 2013 Oct; 105(19):1423-4. PubMed ID: 24052620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.